SBI Healthcare Opportunities Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 26-11-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 1.32 0.77 24.81 24.72 11.54 17.31
S&P BSE Health Care 1.69 0.10 27.35 21.79 10.39 15.26
S&P BSE Health Care - TRI 1.72 0.15 28.05 22.62 11.10 15.35
S&P BSE SENSEX - TRI -6.91 2.25 30.33 18.63 18.11 13.74

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 24.81 24.72 11.54 1.08 1,871.91
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 31.29 27.53 17.47 0.90 5,209.60
UTI Healthcare Fund - Direct Plan - Growth Option Jan 01, 2013 25.87 26.21 13.70 1.25 827.96
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 27.38 27.60 15.53 1.07 557.88

Fund Holdings as on 31-October-2021

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Cipla Ltd.

  • Aurobindo Pharma Ltd.

  • Max Healthcare Institute Ltd.

  • Lupin Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Narayana Hrudayalaya Ltd.

  • Alkem Laboratories Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Gland Pharma Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • TREPS

  • Abbott India Ltd.

  • Fortis Healthcare Ltd.

  • Strides Pharma Science Ltd.

  • Ajanta Pharma Ltd.

  • Solara Active Pharma Sciences Ltd.

  • Gufic Biosciences Ltd.

  • Natco Pharma Ltd.

  • Ami Organics Ltd.

  • Krsnaa Diagnostics Ltd.

  • Vijaya Diagnostic Centre Ltd.

  • Sequent Scientific Ltd.

  • Shreno Ltd.

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

Fund Manager

  • Education:B.E (Electronics),MBA (Finance),C.F.A(USA) Level III candidate
  • Experience:6 years
  • Basic Details:Mr. Desai has close to 6 years of work experience with over 3 years of experience in Indian capital markets. He has been associated with SBI Funds Management Private Limited from May 2008. Prior to join SBI Funds Management Pvt. Ltd. he was a lecturer in Electronics Department with D J Sanghvi College of Engineering, Mumbai.
  • Funds Managed:
  • SBI Healthcare Opportunities Fund
  • Cash

  • Equity

  • Preference Shares

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 01-Jan-2013 and currently has an AUM of ₹1,871.91 crore. SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended up ₹3.77(1.54%)yesterday to ₹249.4172.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .

Fund House Contact

191, Maker Tower 'E' Cuffe Parade Mumbai - 400 005

022 - 22180221-27
022 - 22189663
www.sbimf.com